Drug Shortage Report for TEVA-DULOXETINE

Last updated on 2021-03-11 History
Report ID 133779
Drug Identification Number 02456761
Brand name TEVA-DULOXETINE
Common or Proper name DULOXETINE HCL 60MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) DULOXETINE
Strength(s) 60MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size PP 30
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-10
Estimated end date
Actual end date 2021-03-10
Shortage status Resolved
Updated date 2021-03-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-03-11 French Compare
v3 2021-03-11 English Compare
v2 2021-02-11 French Compare
v1 2021-02-11 English Compare